Literature DB >> 6973324

Factors causing rickets in institutionalised handicapped children on anticonvulsant therapy.

Y Morijiri, T Sato.   

Abstract

An epidemiological study on vitamin D-dependent rickets was carried out in severely handicapped institutionalised children on long-term anticonvulsant therapy. Nine (10%) of 94 patients had overt rickets on the basis of roentgenological bone changes and biochemical indices, but 46 patients in hospital without medication, and 50 epileptic patients attending an outpatient clinic and taking anticonvulsants had no sign of rickets. Causative factors for the development of rickets were evaluated. Administration of anticonvulsive drugs depressed the serum 25-hydroxyvitamin D (25-OHD) level, but this was not the major factor in the development of rickets. Vitamin D intake seemed to be about average in these patients and its supplementation increased their serum 25-OHD level. This serum 25-OHD level was not maintained by supplemental vitamin D, unless the children were exposed to sunlight. These results indicate that although several factors--such as anticonvulsants, low vitamin D intake, and inactivity--are concerned in the development of rickets, the main cause is lack of sun in institutionalised handicapped children.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973324      PMCID: PMC1627455          DOI: 10.1136/adc.56.6.446

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children.

Authors:  K G Tolman; W Jubiz; J J Sannella; J A Madsen; R E Belsey; R S Goldsmith; J W Freston
Journal:  Pediatrics       Date:  1975-07       Impact factor: 7.124

2.  Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults.

Authors:  T J Hahn; B A Hendin; C R Scharp; J G Haddad
Journal:  N Engl J Med       Date:  1972-11-02       Impact factor: 91.245

3.  A rapid assay for 25-OH-vitamin D3 without preparative chromatography.

Authors:  R E Belsey; H F DeLuca; J T Potts
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

4.  Anticonvulsant drugs and vitamin D metabolism.

Authors:  S Livingston; W Berman; L L Pauli
Journal:  JAMA       Date:  1973-06-18       Impact factor: 56.272

5.  Seasonal changes in human plasma levels of 25-hydroxyvitamin D.

Authors:  T C Stamp; J M Round
Journal:  Nature       Date:  1974-02-22       Impact factor: 49.962

6.  Anticonvulsant osteomalacia.

Authors:  A Richens; D J Rowe
Journal:  Br Med J       Date:  1971-12-11

7.  The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone.

Authors:  R Bouillon; J Reynaert; J H Claes; W Lissens; P De Moor
Journal:  J Clin Endocrinol Metab       Date:  1975-12       Impact factor: 5.958

8.  Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients.

Authors:  F Lifshitz; N K Maclaren
Journal:  J Pediatr       Date:  1973-10       Impact factor: 4.406

9.  Rickets in children receiving anticonvulsant drugs. Biochemical and hormonal markers.

Authors:  J L Winnacker; H Yeager; J A Saunders; B Russell; C S Anast
Journal:  Am J Dis Child       Date:  1977-03

10.  Phenobarbital-induced alterations in vitamin D metabolism.

Authors:  T J Hahn; S J Birge; C R Scharp; L V Avioli
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

View more
  10 in total

1.  Nutrition in neurologically impaired children.

Authors: 
Journal:  Paediatr Child Health       Date:  2009-07       Impact factor: 2.253

2.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2009-08-19       Impact factor: 2.253

3.  Factors associated with the biochemical changes in vitamin D and calcium metabolism in institutionalized patients with epilepsy.

Authors:  H Gough; A Bissesar; T Goggin; D Higgins; M Baker; M Crowley; N Callaghan
Journal:  Ir J Med Sci       Date:  1986-06       Impact factor: 1.568

Review 4.  Antiepileptic drug toxicity: definition and mechanism of action.

Authors:  E Beghi; R Di Mascio
Journal:  Ital J Neurol Sci       Date:  1986-04

5.  Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy.

Authors:  Sina Nettekoven; Alexander Ströhle; Birgit Trunz; Maike Wolters; Susanne Hoffmann; Rüdiger Horn; Martin Steinert; Georg Brabant; Ralf Lichtinghagen; Hans-Jürgen Welkoborsky; Ingrid Tuxhorn; Andreas Hahn
Journal:  Eur J Pediatr       Date:  2008-02-13       Impact factor: 3.183

Review 6.  Drug-vitamin D interactions: a systematic review of the literature.

Authors:  Kim Robien; Sarah J Oppeneer; Julia A Kelly; Jill M Hamilton-Reeves
Journal:  Nutr Clin Pract       Date:  2013-01-10       Impact factor: 3.080

7.  The impact of the use of antiepileptic drugs on the growth of children.

Authors:  Herng-Sheng Lee; Shih-Yu Wang; Donald M Salter; Chih-Chien Wang; Shyi-Jou Chen; Hueng-Chuen Fan
Journal:  BMC Pediatr       Date:  2013-12-19       Impact factor: 2.125

8.  Valproic Acid Impacts the Growth of Growth Plate Chondrocytes.

Authors:  Hueng-Chuen Fan; Shih-Yu Wang; Yi-Jen Peng; Herng-Sheng Lee
Journal:  Int J Environ Res Public Health       Date:  2020-05-22       Impact factor: 3.390

9.  Elevated Alkaline Phosphatase in Children: An Algorithm to Determine When a "Wait and See" Approach is Optimal.

Authors:  Jaclyn L Otero; Regino P González-Peralta; Joel M Andres; Christopher D Jolley; Don A Novak; Allah Haafiz
Journal:  Clin Med Insights Pediatr       Date:  2011-06-22

Review 10.  The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism.

Authors:  Hueng-Chuen Fan; Herng-Shen Lee; Kai-Ping Chang; Yi-Yen Lee; Hsin-Chuan Lai; Pi-Lien Hung; Hsiu-Fen Lee; Ching-Shiang Chi
Journal:  Int J Mol Sci       Date:  2016-08-01       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.